Scandinavian Real Heart AB (Publ) (HEART.ST)
SEK 14.2
(2.16%)
SEK 14.2
(2.16%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | -1.68 Million SEK | 0.0% |
| 2022 | - SEK | 0.0% |
| 2021 | - SEK | 0.0% |
| 2020 | - SEK | 0.0% |
| 2019 | - SEK | 0.0% |
| 2018 | - SEK | 0.0% |
| 2017 | - SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| 2015 | - SEK | 0.0% |
| 2014 | - SEK | 0.0% |
| 2013 | - SEK | 0.0% |
| 2012 | - SEK | 0.0% |
| 2011 | - SEK | 0.0% |
| 2010 | - SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - SEK | 0.0% |
| 2024 Q2 | - SEK | 0.0% |
| 2023 Q3 | - SEK | 0.0% |
| 2023 FY | -1.68 Million SEK | 0.0% |
| 2023 Q4 | - SEK | 0.0% |
| 2023 Q1 | - SEK | 0.0% |
| 2023 Q2 | - SEK | 0.0% |
| 2022 Q1 | - SEK | 0.0% |
| 2022 Q2 | - SEK | 0.0% |
| 2022 Q4 | - SEK | 100.0% |
| 2022 Q3 | -5.53 Million SEK | 0.0% |
| 2022 FY | - SEK | 0.0% |
| 2021 Q2 | - SEK | 0.0% |
| 2021 Q1 | - SEK | 0.0% |
| 2021 Q3 | - SEK | 0.0% |
| 2021 Q4 | - SEK | 0.0% |
| 2021 FY | - SEK | 0.0% |
| 2020 Q3 | - SEK | 0.0% |
| 2020 FY | - SEK | 0.0% |
| 2020 Q1 | - SEK | 0.0% |
| 2020 Q4 | - SEK | 0.0% |
| 2020 Q2 | - SEK | 0.0% |
| 2019 FY | - SEK | 0.0% |
| 2019 Q1 | - SEK | 0.0% |
| 2019 Q2 | - SEK | 0.0% |
| 2019 Q3 | - SEK | 0.0% |
| 2019 Q4 | - SEK | 0.0% |
| 2018 Q1 | - SEK | 0.0% |
| 2018 FY | - SEK | 0.0% |
| 2018 Q4 | - SEK | 0.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q2 | - SEK | 0.0% |
| 2017 FY | - SEK | 0.0% |
| 2017 Q3 | - SEK | 0.0% |
| 2017 Q4 | - SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2016 Q2 | - SEK | 0.0% |
| 2016 Q4 | - SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| 2016 Q3 | - SEK | 0.0% |
| 2015 Q2 | - SEK | 0.0% |
| 2015 FY | - SEK | 0.0% |
| 2015 Q4 | - SEK | 0.0% |
| 2015 Q3 | - SEK | 0.0% |
| 2015 Q1 | - SEK | 0.0% |
| 2014 Q4 | - SEK | 0.0% |
| 2014 FY | - SEK | 0.0% |
| 2013 FY | - SEK | 0.0% |
| 2012 FY | - SEK | 0.0% |
| 2011 FY | - SEK | 0.0% |
| 2010 FY | - SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acarix AB (publ) | 6.83 Million SEK | 124.614% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 101.389% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 101.389% |
| Arcoma AB | 28.02 Million SEK | 106.006% |
| Bactiguard Holding AB (publ) | 29.64 Million SEK | 105.678% |
| BICO Group AB (publ) | 493.1 Million SEK | 100.341% |
| Boule Diagnostics AB (publ) | 62.4 Million SEK | 102.698% |
| CellaVision AB (publ) | 126.03 Million SEK | 101.336% |
| Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | 127.529% |
| Chordate Medical Holding AB (publ) | 1.77 Million SEK | 195.056% |
| C-Rad AB (publ) | 64.09 Million SEK | 102.626% |
| Duearity AB (publ) | 4.15 Million SEK | 140.475% |
| Dignitana AB (publ) | 7.41 Million SEK | 122.708% |
| Episurf Medical AB (publ) | 3.7 Million SEK | 145.497% |
| Getinge AB (publ) | 6.41 Billion SEK | 100.026% |
| Iconovo AB (publ) | -4.86 Million SEK | 65.377% |
| Integrum AB (publ) | 22.36 Million SEK | 107.528% |
| Luxbright AB (publ) | 8000.00 SEK | 21142.138% |
| Mentice AB (publ) | 14.1 Million SEK | 111.935% |
| OssDsign AB (publ) | 4.3 Million SEK | 139.112% |
| Paxman AB (publ) | 19.99 Million SEK | 108.417% |
| Promimic AB (publ) | 330 Thousand SEK | 610.112% |
| Qlife Holding AB (publ) | 7.29 Million SEK | 123.085% |
| SciBase Holding AB (publ) | 11.91 Million SEK | 114.123% |
| ScandiDos AB (publ) | 22.69 Million SEK | 107.419% |
| Sectra AB (publ) | 36.59 Million SEK | 104.601% |
| Sedana Medical AB (publ) | 42.97 Million SEK | 103.917% |
| Senzime AB (publ) | 20.34 Million SEK | 108.276% |
| SpectraCure AB (publ) | 1.00 SEK | 168337200.0% |
| Stille AB | 66.55 Million SEK | 102.529% |
| Vitrolife AB (publ) | 413 Million SEK | 100.408% |
| Xvivo Perfusion AB (publ) | 141.6 Million SEK | 101.189% |